Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 12-2022 | |
| Operating Expenses | 9,564 | 6,630 | 0 |
| Operating Income | -9,564 | -6,630 | N/A |
| Other Income | 856 | 221 | 0 |
| Pre-tax Income | -8,708 | -6,409 | 0 |
| Income Tax | 1 | 2 | N/A |
| Net Income Continuous | -8,709 | -6,411 | N/A |
| Net Income | $-8,709 | $-6,411 | $N/A |
| EPS Basic Total Ops | -5.70 | -4.45 | N/A |
| EPS Basic Continuous Ops | -5.70 | -4.45 | N/A |
| EPS Diluted Total Ops | -5.70 | -4.45 | N/A |
| EPS Diluted Continuous Ops | -5.70 | -4.45 | N/A |
| EBITDA(a) | $-9,541 | $-6,630 | $N/A |